Michigan hospitals report varied prenatal and newborn testing policies

Variation in Prenatal and Newborn Toxicology Testing Policies in Michigan Hospitals.

Journal of addiction medicine β€’ β€’ Related
πŸ€–

AI Summary

This cross-sectional survey examined how Michigan birth hospitals handle prenatal and newborn toxicology testing and referrals to child protective services, including policies related to cannabis exposure. Of the 76 hospitals invited, 25 completed the survey. Responding hospitals reported varied testing approaches: 28% (7/25) used universal prenatal testing, while 68% (17/25) used risk-based prenatal testing; most used risk-based testing for newborns. The most commonly reported risk-based indication was no prenatal care (12/17).

Professional guidelines recommend informed consent for prenatal toxicology tests, but 56% (14/25) of respondents required it for prenatal testing, and 20% (5/25) required parental consent for newborn testing. The authors conclude that hospital policies vary and identify opportunities to improve ethical treatment of parents and newborns. Because only 33% of invited hospitals responded, this survey may not represent all Michigan hospitals; it also describes reported policies, not how testing or referrals affected families. This is an abstract-based summary and cannot establish the prevalence of these practices across the state.

πŸ’‘ Key Findings

1
Among responding hospitals, prenatal toxicology testing policies varied: 28% reported universal testing and 68% risk-based testing.
High
95%
2
Most responding hospitals used risk-based newborn testing; no prenatal care was the most commonly reported indication for risk-based testing.
High
95%
3
Informed consent policies were inconsistent: 56% required consent for prenatal testing, while 20% required parental consent for newborn testing.
High
95%
4
The survey had a 33% response rate, limiting how confidently its findings can be generalized to all Michigan birth hospitals.
High
99%

πŸ“„ Original Abstract

OBJECTIVES: This study examines hospital policies on prenatal and newborn toxicology testing, and subsequent referral to child protective services (CPS) for suspected abuse and neglect in Michigan. We assessed variability between hospitals, alignment with state law, and consistency with professional guidelines. METHODS: This cross-sectional survey was conducted between February 1, 2024, and September 1, 2024. All 76 birth hospitals in Michigan were invited to participate. The 10-question survey addressed hospital protocols for prenatal and newborn toxicology testing, indications for testing in risk-based protocols, informed consent policies, protocols for reporting to child protective services, and specific policies for cannabis exposure and patients receiving medication treatment for opioid use disorder. RESULTS: Of 76 birth hospitals in Michigan, 25 completed the survey (response rate 33%). Hospitals reported variability in prenatal and newborn toxicology testing policies. Of respondents, 28% (7/25) reported universal prenatal toxicology testing and 68% (17/25) reported risk-based testing. Most hospitals (23/25) used a risk-based testing strategy for newborns. The most common risk-based indication was no prenatal care (12/17). Although guidelines recommend informed consent for all prenatal toxicology tests, only 56% (14/25) of hospitals required informed consent for prenatal toxicology testing and only 20% (5/25), required informed consent from a parent for newborn toxicology testing. CONCLUSIONS: Variability in hospital prenatal and newborn toxicology testing policies, even within a single state's regulatory framework, highlights opportunities for quality improvement at the level of hospital policy to improve the ethical treatment of birth parents and newborns with potential exposures to substance use during pregnancy.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.